Filing Flows › Comparisons › ALNY vs ELAN
Alnylam Pharmaceuticals vs Elanco Animal Health: ALNY and ELAN compared
Alnylam Pharmaceuticals is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $1.3B for Elanco Animal Health (Q3 2026). Alnylam Pharmaceuticals is growing faster (+17% against +11% a year earlier). Alnylam Pharmaceuticals is more profitable, with an operating margin of 23.7% against 1.9%.
Where the money goes: ALNY and ELAN
Alnylam Pharmaceuticals (ALNY) · Q3 2026
Alnylam Pharmaceuticals, Q3 2026: revenue $1.5B (+17% year over year), operating margin 23.7%, net earnings $2.2B, operating cash flow $341M. The chart follows the revenue to costs, profit and cash.
Elanco Animal Health (ELAN) · Q3 2026
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
| Alnylam Pharmaceuticals (ALNY) | Elanco Animal Health (ELAN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.5B | $1.3B |
| Revenue growth, Y/Y | +17% | +11% |
| Gross margin | — | 56.9% |
| Operating margin | 23.7% | 1.9% |
| Net earnings | $2.2B | $18.0M |
| Net margin | 148.6% | 1.4% |
| Operating cash flow | $341M | $216M |
| Free cash flow | $271M | $156M |
| Market value | $21.6B | $13.1B |
| P/E | 8.0× | — |
| Analysts’ mean target | $302.48 | $30.69 |
Where the revenue comes from
Alnylam Pharmaceuticals
- Net product revenues: $1.3B (89%)
- Total Rare: $142M (10%)
- ONPATTRO: $19.6M (1%)
Elanco Animal Health
- Farm Animal:: $631M (50%)
- Pet Health: $608M (48%)
- Contract Manufacturing: $26.0M (2%)
Questions
Which is bigger, Alnylam Pharmaceuticals or Elanco Animal Health?
Alnylam Pharmaceuticals is the larger company: $1.5B of revenue in its latest quarter (Q3 2026) against $1.3B for Elanco Animal Health (Q3 2026).
Is Alnylam Pharmaceuticals or Elanco Animal Health growing faster?
Alnylam Pharmaceuticals is growing faster (+17% against +11% a year earlier).
Which is more profitable, Alnylam Pharmaceuticals or Elanco Animal Health?
Alnylam Pharmaceuticals is more profitable, with an operating margin of 23.7% against 1.9%.
More: Alnylam Pharmaceuticals earnings · how Alnylam Pharmaceuticals makes money · Elanco Animal Health earnings · how Elanco Animal Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.